Page 1 of Clinical Trials for Response Criteria, 2763 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1
Last Updated: February 8, 2012
Condition(s): Metastatic Melanoma
2
Recruiting
Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Last Updated: April 3, 2012
Condition(s): Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
3
Completed
Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis
Last Updated: January 12, 2007
Condition(s): Ankylosing Spondylitis
4
Completed
Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
Last Updated: November 22, 2011
Condition(s): Ankylosing Spondylitis
5
Recruiting
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus
Last Updated: May 16, 2012
Condition(s): Systemic Lupus Erythematosus
6
Recruiting
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)
Last Updated: May 23, 2012
Condition(s): Systemic Lupus Erythematosus
7
Recruiting
Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha Antagonist
Last Updated: March 29, 2012
Condition(s): Rheumatoid Arthritis
8
Active, not recruiting
Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.
Last Updated: May 8, 2012
Condition(s): Rheumatoid Arthritis
9
Active, not recruiting
Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.
Last Updated: March 28, 2012
Condition(s): Rheumatoid Arthritis
10
Recruiting
Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis
Last Updated: May 18, 2012
Condition(s): Rheumatoid Arthritis
11
Recruiting
Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
Last Updated: March 28, 2012
Condition(s): Multiple Myeloma
12
Recruiting
A Study of Iguratimod in Patients With Active Rheumatoid Arthritis
Last Updated: May 18, 2012
Condition(s): Rheumatoid Arthritis
13
Completed
Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis
Last Updated: May 3, 2012
Condition(s): Early Rheumatoid Arthritis
14
Terminated
Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI
Last Updated: May 18, 2012
Condition(s): HIV Infections
15
Recruiting
Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab
Last Updated: March 29, 2012
Condition(s): Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
16
Recruiting
Safety and Efficacy of the Combination of Diacerein 100 mg Daily and MTX Versus MTX Alone in the Treatment of Early Rheumatoid Arthritis (RA)
Last Updated: October 10, 2011
Condition(s): Rheumatoid Arthritis
17
Active, not recruiting
A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA)
Last Updated: March 22, 2012
Condition(s): Rheumatoid Arthritis
18
Recruiting
Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis (AS) and Inadequate Response to ≥2 NSAIDs
Last Updated: November 30, 2011
Condition(s): Ankylosing Spondylitis (AS) and Inadequate Response to ≥2 NSAIDs.
19
Recruiting
Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
Last Updated: February 21, 2012
Condition(s): Melanoma; Malignant Melanoma
20
Active, not recruiting
Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis
Last Updated: March 5, 2012
Condition(s): Spondyloarthropathies

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Response+Criteria

Page 1 of Clinical Trials for Response Criteria, 2763 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About